Fox Investigation for New Discovery of Biomarkers

Completed

Conditions studied: Parkinson's Disease

In brief

This is an observational, multi-center study to assess clinical features and biologic biomarkers in Parkinson's disease (PD) patients compared to healthy controls (HC). The primary objective of this study is to discover clinical and biologic markers of PD for use in clinical trials of disease-modifying therapies.

Key facts

Study ID

NCT01705327

Run by

Michael J. Fox Foundation for Parkinson's Research

People needed

240

Starts

2012-10-01

Expected to finish

2015-03-01

Last updated by the study team

2015-10-05

Who can join

Age: 55 and older, up to 93. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Rush University Medical Center — Chicago, Illinois, United States
• University of Chicago — Chicago, Illinois, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Columbia University Medical Center — New York, New York, United States
• Cornell University Medical Center — New York, New York, United States
• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.